Randall Moreadith
Chief Scientific Officer at Serina Therapeutics, Inc. (SER)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $501K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 24SEC | SERSerina Therapeutics, Inc. | Sell Plan | 6,500 | $2.86 | $19K | -30.1% |
| Mar 20SEC | SERSerina Therapeutics, Inc. | Sell Plan | 39,000 | $2.50 | $98K | -20.0% |
| Feb 3SEC | SERSerina Therapeutics, Inc. | Sell Plan | 6,500 | $3.03 | $20K | -34.0% |
| Jan 29SEC | SERSerina Therapeutics, Inc. | Sell Plan | 6,500 | $3.57 | $23K | -44.0% |
| Jan 23SEC | SERSerina Therapeutics, Inc. | Sell Plan | 2,500 | $2.95 | $7K | -32.2% |
| Jan 21SEC | SERSerina Therapeutics, Inc. | Sell Plan | 2,000 | $3.07 | $6K | -34.9% |
| Jan 21SEC | SERSerina Therapeutics, Inc. | Sell Plan | 2,000 | $3.00 | $6K | -33.3% |
| Jan 14SEC | SERSerina Therapeutics, Inc. | Sell Plan | 5,416 | $2.50 | $14K | -20.0% |
| Jan 14SEC | SERSerina Therapeutics, Inc. | Sell Plan | 1,084 | $2.50 | $3K | -20.0% |
| Jan 9SEC | SERSerina Therapeutics, Inc. | Sell Plan | 13,000 | $2.69 | $35K | -25.7% |
| Dec 29SEC | SERSerina Therapeutics, Inc. | Sell Plan | 4,100 | $2.60 | $11K | -23.1% |
| Dec 23SEC | SERSerina Therapeutics, Inc. | Sell Plan | 5,673 | $2.67 | $15K | -25.1% |
| Dec 17SEC | SERSerina Therapeutics, Inc. | Sell Plan | 3,227 | $2.96 | $10K | -32.4% |
| Dec 16SEC | SERSerina Therapeutics, Inc. | Sell Plan | 1,700 | $3.26 | $6K | -38.7% |
| Dec 12SEC | SERSerina Therapeutics, Inc. | Sell Plan | 3,555 | $3.24 | $12K | -38.3% |
| Dec 11SEC | SERSerina Therapeutics, Inc. | Sell Plan | 600 | $3.31 | $2K | -39.6% |
| Dec 11SEC | SERSerina Therapeutics, Inc. | Sell Plan | 645 | $3.35 | $2K | -40.3% |
| Dec 4SEC | SERSerina Therapeutics, Inc. | Sell Plan | 1,500 | $3.91 | $6K | -48.8% |
| Dec 4SEC | SERSerina Therapeutics, Inc. | Sell Plan | 5,000 | $3.52 | $18K | -43.2% |
| Nov 26SEC | SERSerina Therapeutics, Inc. | Sell Plan | 5,9655,965 held (−50%) | $3.90 | $23K | -48.7% |
| Nov 25SEC | SERSerina Therapeutics, Inc. | Sell Plan | 535 | $3.94 | $2K | -49.2% |
| Nov 19SEC | SERSerina Therapeutics, Inc. | Sell Plan | 6,500 | $3.75 | $24K | -46.7% |
| Nov 12SEC | SERSerina Therapeutics, Inc. | Sell Plan | 6,500 | $4.10 | $27K | -51.2% |
| Nov 6SEC | SERSerina Therapeutics, Inc. | Sell Plan | 3,398 | $4.24 | $14K | -52.8% |
| Nov 5SEC | SERSerina Therapeutics, Inc. | Sell Plan | 3,102 | $4.40 | $14K | -54.5% |
| Oct 29SEC | SERSerina Therapeutics, Inc. | Sell Plan | 5,551 | $4.96 | $28K | -59.7% |
| Oct 28SEC | SERSerina Therapeutics, Inc. | Sell Plan | 949 | $5.19 | $5K | -61.5% |
| Oct 21SEC | SERSerina Therapeutics, Inc. | Sell Plan | 6,500 | $4.97 | $32K | -59.8% |
| Oct 14SEC | SERSerina Therapeutics, Inc. | Sell Plan | 4,326 | $5.20 | $22K | -61.5% |
- Sell
Chief Scientific Officer Randall Moreadith sold $19K of SER at $2.86 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Randall Moreadith sold $98K of SER at $2.50 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Randall Moreadith sold $20K of SER at $3.03 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Randall Moreadith sold $23K of SER at $3.57 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Randall Moreadith sold $7K of SER at $2.95 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Randall Moreadith sold $6K of SER at $3.07 — pre-scheduled 10b5-1 plan sale.